- Home
- UG vs KRON Comparison
UG vs KRON Comparison
Compare UG & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UG
- KRON
- Stock Information
- Founded
- UG 1942
- KRON 2017
- Country
- UG United States
- KRON United States
- Employees
- UG N/A
- KRON N/A
- Industry
- UG Package Goods/Cosmetics
- KRON Medicinal Chemicals and Botanical Products
- Sector
- UG Consumer Discretionary
- KRON Health Care
- Exchange
- UG Nasdaq
- KRON Nasdaq
- Market Cap
- UG 36.9M
- KRON 41.5M
- IPO Year
- UG N/A
- KRON 2020
- Fundamental
- Price
- UG $8.13
- KRON $0.87
- Analyst Decision
- UG
- KRON Buy
- Analyst Count
- UG 0
- KRON 3
- Target Price
- UG N/A
- KRON $1.63
- AVG Volume (30 Days)
- UG 3.7K
- KRON 1.4M
- Earning Date
- UG 08-08-2025
- KRON 08-07-2025
- Dividend Yield
- UG 8.57%
- KRON N/A
- EPS Growth
- UG 4.93
- KRON N/A
- EPS
- UG 0.63
- KRON N/A
- Revenue
- UG $11,408,154.00
- KRON $9,192,000.00
- Revenue This Year
- UG N/A
- KRON N/A
- Revenue Next Year
- UG N/A
- KRON N/A
- P/E Ratio
- UG $13.01
- KRON N/A
- Revenue Growth
- UG N/A
- KRON 21.16
- 52 Week Low
- UG $7.73
- KRON $0.65
- 52 Week High
- UG $16.25
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- UG 46.44
- KRON 64.27
- Support Level
- UG $8.12
- KRON $0.87
- Resistance Level
- UG $8.50
- KRON $0.90
- Average True Range (ATR)
- UG 0.17
- KRON 0.02
- MACD
- UG -0.00
- KRON 0.01
- Stochastic Oscillator
- UG 26.09
- KRON 87.65
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.